Skip to main content
. 2017 Mar 27;13(3):e1006683. doi: 10.1371/journal.pgen.1006683

Table 1. Major clinical findings in 51 individuals with germline mutations in SETBP1.

NA stands for “Not Assessed”.

Residue affected in SETBP1 E862 S867 D868 S869 G870 I871 T873 All degron-affecting mutations (868–871)
Male(M):female(F) 1F 2 F 8F:7 M 2F 5F: 10M 6F:9M 1M 21F:26M
Craniofacial findings
Microcephaly 1/1 1/2 10/12 1/2 10/13 8/11 0/1 29/39 74.4%
SGS facial gestalt 0/1 2/2 15/15 2/2 15/15 15/15 0/1 47/47 100.0%
Congenital anomalies
Hydronephrosis 0/1 0/2 15/15 2/2 14/15 14/15 0/1 45/47 95.7%
Genital abnormalities 1/1 0/2 14/15 1/2 14/15 12/13 0/1 41/45 91.1%
Cardiac defects 0/1 1/2 10/15 1/2 4/13 5/13 0/1 20/43 46.5%
Tracheo/laryngomalacia 0/1 0/1 3/4 0/2 3/8 2/2 0/1 8/16 50.0%
Inguinal hernia 0/1 0/1 2/4 0/2 6/8 0/1 0/1 8/15 53.3%
Alacrima 0/1 2/2 6/10 0/2 7/9 6/6 0/1 19/27 70.4%
Neurodevelopmental anomalies
Developmental delay 1/1 2/2 14/14 2/2 13/13 10/10 1/1 39/39 100.0%
Seizures 0/1 2/2 15/15 2/2 13/14 12/13 0/1 42/44 95.5%
Spasticity and/or hypertonia 0/1 1/1 4/4 1/2 8/10 4/4 1/1 17/20 85.0%
Vision impairment 1/1 1/1 7/10 1/2 7/8 5/6 0/1 20/26 76.9%
Hearing impairment 0/1 0/1 9/9 0/1 7/8 8/9 0/1 24/27 88.9%
Progressive failure to thrive 0/1 0/1 10/11 1/2 13/13 8/9 0/1 32/35 91.4%
Brain MRI/CT
Ventriculomegaly 0/1 NA 6/12 2/2 11/14 7/14 0/1 26/42 61.9%
Underdeveloped corpus callosum 0/1 NA 9/11 0/2 12/13 10/12 0/1 31/38 81.6%
Cortical atrophy or dysplasia 0/1 NA 8/10 0/2 7/10 3/11 1/1 18/33 54.5%
Choroid plexus cysts 0/1 NA 2/9 0/2 8/10 3/10 0/1 13/31 41.9%
Radiological findings
Sclerotic base of skull or mastoid NA NA 9/10 0/1 5/5 5/7 NA 19/23 82.6%
Hypoplastic distal phalanges 0/1 NA 8/9 0/1 8/9 5/6 NA 21/25 84.0%
Broad ribs 0/1 NA 10/13 2/2 6/7 9/9 NA 27/31 87.1%
Hypoplastic/underossified pubic bones 0/1 NA 6/7 2/2 4/5 6/6 NA 18/20 90.0%
Tumors 0/1 0/2 5/11 0/2 1/11 1/9 0/1 7/33 21.2%